AIM: To improve the results of New therapeutic strategies in hepatocellular carcinoma (HCC). We have conducted a phase Ⅱ study with pegylated liposomal doxorub
<正> Platelet-activating factor(PAF)is a potentproinflammatory phospholipid mediator that belongsto a family of biologically active,structurally relatedalkyl ph